What is the Impact Factor of Diabetes Technology & Therapeutics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Diabetes Technology & Therapeutics is 7.40, ranking in quartile Q1 of Web of Science (SCIE).

Is Diabetes Technology & Therapeutics indexed in Web of Science or Scopus?

Yes, Diabetes Technology & Therapeutics is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 2.663 (Q1) and an H-index of 116.

Who publishes Diabetes Technology & Therapeutics and what is the Article Processing Charge (APC)?

Diabetes Technology & Therapeutics is published by Mary Ann Liebert Inc.. The estimated Article Processing Charge (APC) is approximately $4,039 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Diabetes Technology & Therapeutics?

The official ISO-4 abbreviation of Diabetes Technology & Therapeutics is "DIABETES TECHNOL. THER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #875Top JournalHybrid

Diabetes Technology & Therapeutics

Abbreviation (ISO):DIABETES TECHNOL. THER

•

Identifier (ISSN):1520-9156(Print)/1557-8593(Online)

•

Publisher:Mary Ann Liebert Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

7.4↑ +1.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diabetes Technology & Therapeutics

WoS Q1

Annual Impact Factor Metric

Current (2026):7.4

Scopus SJR & RankScopus Q1

2.663

#875

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

116

116 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate17.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

118articles/year

23.73% Gold OA•97.5% Original Research

Aims & Scope

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Topics Covered (Recognized by AI)

Medicine99.6%Biology98.2%Endocrinology96.1%Diabetes mellitus95%Internal medicine81.2%Biotechnology62.7%Insulin62.1%Type 1 diabetes47.8%Type 2 diabetes42%Glycemic39.2%Pathology37.1%Intensive care medicine28.1%Surgery26%Chemistry25.9%Mathematics23.3%Continuous glucose monitoring22.7%Hypoglycemia20.1%

Primary Research Areas

Medicine Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank21/198

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank16/198

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	21/198	Q1
ENDOCRINOLOGY & METABOLISM	JCISCIE	16/198	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF7.4

Articles / Year157

Total Citations92

2025

IF6.3

Articles / Year216

Total Citations737

2024

IF5.7

Articles / Year157

Total Citations1,988

2023

IF5.4

Articles / Year149

Total Citations2,951

2022

IF7.337

Articles / Year132

Total Citations2,449

Year	Impact Factor	Articles / Year	Total Citations
2026	7.4	157	92
2025	6.3	216	737
2024	5.7	157	1,988
2023	5.4	149	2,951
2022	7.337	132	2,449
2021	6.118	165	3,829
2020	4.392	146	5,270
2019	4.488	186	7,640
2018	2.921	146	6,232
2017	—	159	5,543
2016	—	156	4,729
2015	—	145	4,227

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #875Scopus Q1SCImago Profile

Scopus Coverage:1999-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyHealth ProfessionsMedicine

Scopus Citation Rank (SJR)Q1

2.663

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.68

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,039 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,681

3-Year Documents432

Citable Documents389

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate52.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1

Endocrinology, Diabetes and MetabolismQ1

Medical Laboratory TechnologyQ1

Medicine (miscellaneous)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 17.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

1区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diabetes Technology & Therapeutics (abbr: DIABETES TECHNOL. THER, ISSN: 1520-9156) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 1999. The periodical holds a Journal Impact Factor (JIF) of 7.40, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.663 (Q1), an H-index of 116.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 118 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,039 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.